TrialAntimicrobial agents and chemotherapy2017

The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies.

John F Kokai-Kun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.